Technology, Healthcare Jan 28, 2022 07:49 PM (GMT+8) · EqualOcean
Kangtai biology released a performance forecast. It is expected that the net profit attributable to the parent company will be RMB 1.2 billion-1.4 billion in 2021, with a year-on-year increase of 76.68% - 106.13%. During the reporting period, the company continued to strengthen product R & D and international cooperation, orderly promote the listing and sales of new products, continuously optimize the layout of marketing network, strengthen market promotion, promote the steady increase of product sales, and the net profit of the company increased significantly compared with the same period last year.

This text is a result of machine translation.

Related companies：